View in EDS

A Novel High Dose Chemotherapy Strategy With Bendamustine in Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: A Phase I-II Study on 44 Patients

Saved in:
Bibliographic Details
Title: A Novel High Dose Chemotherapy Strategy With Bendamustine in Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: A Phase I-II Study on 44 Patients
Authors: Visani, G.1, Malerba, L.1, Stefani, P.M.2, Capria, S.3, Galieni, P.4, Gaudio, F.5, Specchia, G.5, Meloni, G.3, Gherlinzoni, F.2, Giardini, C.1, Falcioni, S.4, Loscocco, F.1, Cuberli, F.6, Gobbi, M.6, Sarina, B.7, Santoro, A.7, Rocchi, M.8, Ocio, E.M.9, Caballero, D.M.9, Isidori, A.1
Source: Biology of Blood & Marrow Transplantation. Feb2011 Supplement, Vol. 17 Issue 2, pS196-S196. 1p.
Database: Academic Search Ultimate
Description
ISSN:10838791
DOI:10.1016/j.bbmt.2010.12.137